Back to today’s briefing

Story perspectives

Vaccinating Pregnant Women Cuts Newborn RSV Hospitalizations 72%

7/20/2025

44 5

Summary

Story summary

A groundbreaking UK study reveals that vaccinating pregnant women against respiratory syncytial virus (RSV) slashes newborn hospitalizations by an impressive 72%. By delivering vital antibodies to the fetus, the vaccine shields infants in their crucial first six months. Experts urge vaccination starting at 28 weeks to bolster this protective shield, potentially alleviating winter hospital strains.

1 of 1

Story summary

A groundbreaking UK study reveals that vaccinating pregnant women against respiratory syncytial virus (RSV) slashes newborn hospitalizations by an impressive 72%. By delivering vital antibodies to the fetus, the vaccine shields infants in their crucial first six months. Experts urge vaccination starting at 28 weeks to bolster this protective shield, potentially alleviating winter hospital strains.